Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Tofacitinib might be used to treat hair loss.

5-aminolevulinic acid therapy reduces acne by decreasing fat production in skin cells.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Fluphenazine and iloprost can induce hair growth.

Tribulus terrestris extract significantly increases MSH expression and melanin production in mouse hair follicles.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

More research is needed to understand if GLP-1 agonists affect hair health.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Liposomes can improve the effectiveness of skin treatments.

Cepharanthine shows promise as a COVID-19 treatment.

Botanical extracts can help treat hair loss in people with certain genetic conditions.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.